Skip to main content

Table 2 KEGG pathways of the 42 differentially expressed miRNAs

From: Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs

KEGG Pathway

Count

%

P-value

Fold Enrichment

Bonferroni

Pathways in cancer

158

3.62

1.19E-13

1.69

3.49E-11

FoxO signalling pathway

68

1.56

2.26E-11

2.14

6.65E-09

Glioma

40

0.92

3.67E-10

2.59

1.08E-07

Chronic myeloid leukaemia

42

0.96

1.22E-09

2.46

3.58E-07

Prostate cancer

47

1.08

5.20E-09

2.25

1.53E-06

Neurotrophin signalling pathway

56

1.28

7.08E-08

1.97

2.08E-05

Cell cycle

57

1.30

1.01E-07

1.94

2.97E-05

ErbB signalling pathway

44

1.01

1.37E-07

2.13

4.03E-05

Hepatitis B

63

1.44

2.44E-07

1.83

7.16E-05

p53 signalling pathway

36

0.82

3.64E-07

2.27

1.07E-04

PI3K-Akt signalling pathway

122

2.79

6.84E-07

1.49

2.01E-04

Viral carcinogenesis

80

1.83

1.08E-06

1.65

3.16E-04

Non-small cell lung cancer

31

0.71

1.24E-06

2.33

3.64E-04

Bladder cancer

25

0.57

1.76E-06

2.57

5.17E-04

Renal cell carcinoma

34

0.78

1.82E-06

2.21

5.35E-04

Pancreatic cancer

34

0.78

1.82E-06

2.21

5.35E-04

Proteoglycans in cancer

77

1.76

3.21E-06

1.62

9.43E-04

TGF-beta signalling pathway

40

0.92

3.82E-06

2.01

0.001123

MAPK signalling pathway

93

2.13

4.08E-06

1.54

0.001198

Signalling pathways regulating pluripotency of stem cells

58

1.33

4.85E-06

1.75

0.001425

Fc epsilon RI signalling pathway

34

0.78

6.49E-06

2.11

0.001905

Small cell lung cancer

39

0.89

1.52E-05

1.93

0.004457

Ras signalling pathway

82

1.88

2.03E-05

1.53

0.00595

Melanoma

34

0.78

2.05E-05

2.02

0.005999

T cell receptor signalling pathway

44

1.01

3.41E-05

1.80

0.009978

Endocytosis

90

2.06

4.31E-05

1.47

0.01259

Epstein-Barr virus infection

70

1.60

5.12E-05

1.55

0.014945

Hippo signalling pathway

58

1.33

6.68E-05

1.62

0.019459

Insulin signalling pathway

54

1.24

7.01E-05

1.65

0.020398

Thyroid hormone signalling pathway

46

1.05

1.15E-04

1.70

0.033145

Oestrogen signalling pathway

41

0.94

1.50E-04

1.75

0.043177

Acute myeloid leukaemia

27

0.62

1.56E-04

2.03

0.044742

Rap1 signalling pathway

74

1.69

1.58E-04

1.49

0.045381

Colorectal cancer

29

0.66

1.59E-04

1.97

0.045785

  1. KEGG pathways were generated by DAVID functional annotation. Only terms with a Bonferroni-adjusted p ≤ 0.05 are presented